Neural Stem Cells as an Allogeneic Stem Cell-Based Platform for Oncolytic Virotherapy

Time: 10:30 am
day: Pre-Conference Day


  • NSC-based virotherapy has shown promising results in preclinical studies, demonstrating improved tumor targeting, enhanced virus replication, and increased antitumor efficacy compared to traditional oncolytic viral therapy alone
  • NSCs can potentially be combined with other therapeutic modalities, such as chemotherapy or immunotherapy, to create synergistic effects and improve overall treatment outcomes